TME Pharma N.V.'s market cap is currently €10.69M. The company's EPS TTM is €-0.026; its P/E ratio is ―; TME Pharma N.V. is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
